Ivosidenib

Ivosidenib
Trade Name
Orphan Indication Bile duct cancer
USA Market Approval USA
USA Designation Date 2017-04-26 00:00:00
Sponsor Agios Pharmaceuticals, Inc.;88 Sidney Street;Cambridge, Massachusetts, 02139